Vascepa is a prescription drug used to reduce the risk of heart attack, stroke, and other cardiovascular events in people with high levels of triglycerides. According to the sources provided, there are no specific restrictions mentioned for Vascepa savings alerts. However, there are some important details to consider regarding the cost and availability of Vascepa.
Vascepa is a brand-name drug that contains the active ingredient icosapent ethyl. It is currently protected by a patent that will expire in 2030 [1]. This means that there are no generic versions of Vascepa available on the market yet. However, the manufacturer of Vascepa, Amarin Pharma Inc., offers a savings program called Vascepa Savings Alerts [2]. This program provides eligible patients with savings on their out-of-pocket costs for Vascepa prescriptions.
According to the Vascepa website, the savings alerts program is available to all eligible patients, regardless of their insurance status or income level [2]. Patients can sign up for the program online and receive alerts when there are new savings opportunities available. The program also offers a co-pay card that can be used at participating pharmacies to reduce the cost of Vascepa prescriptions.
It's worth noting that there are some recent developments related to the availability and cost of Vascepa. In December 2020, the FDA approved a generic version of icosapent ethyl, the active ingredient in Vascepa, called Epanova [3]. However, Epanova has not yet been launched on the market due to manufacturing issues. In the meantime, Amarin has lowered the price of Vascepa for most patients, making it more affordable than the generic version [4].
In conclusion, there are no specific restrictions mentioned for Vascepa savings alerts. Eligible patients can sign up for the program and receive alerts when there are new savings opportunities available. Additionally, recent developments related to the availability and cost of Vascepa suggest that it may be a more affordable option than the generic version of icosapent ethyl.
Sources:
[1] Drug Patent Watch. Vascepa Trademark Details. https://www.drugpatentwatch.com/p/tradename/VASCEPA. Accessed 29 March 2021.
[2] Vascepa. Vascepa Savings Alerts. https://www.vascepa.com/savings-alerts. Accessed 29 March 2021.
[3] FDA. FDA approves first generic for the treatment of high triglycerides. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-treatment-high-triglycerides. Accessed 29 March 2021.
[4] RxInsider. Vascepa® (icosapent ethyl) is available at a lower cost than generic icosapent ethyl for most patients. https://rxinsider.com/market-buzz/?p=11988-vascepa-reg-icosapent-ethyl-is-available-at-a-lower-cost-than-generic-icosapent-ethyl-for-most-patients. Accessed 29 March 2021.